SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Hawkish Federal Reserve commentary, particularly Kevin Warshs emphasis on inflation and potential rate hikes, has driven a sharp selloff in rate-sensitive fintech stocks including SoFi. Traders are split between viewing higher rates as a major headwind and arguing that SoFis guidance already accounts for two hikes, making the decline an opportunity to accumulate.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Executive commentary and healthcare-industry endorsements of SELLASs GPS as a potential AML game changer have focused attention on the approaching Phase 3 REGAL milestones, including the unconfirmed 80th-event trigger and subsequent unblinded data. Traders are broadly bullish on the trials prolonged survival signals, while bears dispute the trial design and statistical interpretation and note that 78 events remains the last officially confirmed count.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops preliminary second-quarter update and amended convertible-note exchange are driving attention, with traders focused on improved operating profitability and a cap on share issuance through a partial cash settlement. Bulls view the reduced dilution as supportive of buybacks and potential short covering, while bears point to weaker sales, investment-driven earnings, and continued uncertainty around management and the warrants.

Corvex, Inc. is an AI cloud computing company, which specializes in GPU-accelerated infrastructure for AI workloads. Its products include GPU Clusters, Confidential Computing, Inference as a Service and GPU Node. The firm offers solutions include AI model builders, enterprises, federal and sovereign solutions. The company was founded by Seth Mitchell Demsey, Jay Crystal on October 21, 2024 and is headquartered in Arlington, VA.

Corvex Inc.

Movano Inc

A multi-year agreement to provide NVIDIA Blackwell GPU clusters, alongside Corvexs data-center expansion and combination with Movano, is driving attention. Traders are debating whether the AI-infrastructure story and perceived low float could fuel a short squeeze, while others warn about dilution, limited execution history, and sharp momentum-driven reversals.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

The ongoing control battle between former CEO Vishal Garg and Betters board is driving attention, including a court denial of the boards temporary restraining order and Gargs continuing proxy campaign. Traders are split over which side would better support shareholders, while low float and elevated short interest are fueling speculation about a potential short squeeze.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

Q2 earnings sparked attention after an earnings-per-share miss and tariff/wind-related concerns outweighed a revenue beat, higher full-year guidance, and record backlog tied to power-grid and AI data-center demand. Traders are divided between viewing the selloff as a sign of overvaluation or execution risk and treating it as an overreaction and long-term buying opportunity.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Positive Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran in severe hypertriglyceridemia, including reduced triglycerides and acute-pancreatitis events, are driving attention and expectations for a broader FDA filing. Traders are broadly bullish on the data and Arrowheads RNAi platform, though many are debating the stocks sell-the-news decline and attributing the weakness to options positioning and market mechanics.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Renewed Middle East conflict and uncertainty around Strait of Hormuz access are lifting crude-price expectations and drawing attention to Chevron as a major integrated oil producer. Traders are divided between an oil-and-energy bullish view if supply disruptions persist and a bearish view that de-escalation or peace talks could remove the geopolitical premium; Chevrons Venezuela expansion and strong earnings are secondary themes.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

GTA VIs extended gameplay reveal and pre-release marketing have driven attention to Take-Two, with traders focusing on expected blockbuster sales, preorders, and future recurring revenue from GTA Online. Enthusiasm over the games scale and visuals is offset by debate about leaks, performance, potential delays, conservative guidance, and whether much of the launch upside is already priced in.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Attention is centered on the reported Jasmy/JANCTION collaboration with Panasonic Advanced Technology, involving distributed GPU computing, Smart Render, and potential AI and enterprise use cases. Traders are broadly bullish on the commercial-utility implications, while skeptics note that direct JASMY token demand and adoption remain unconfirmed and continue to debate delisting and low-volume concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MDT's Q1 Earnings on Deck: How Should You Play the Stock Now?

Medtronic's Q1 results may reflect strong growth across Cardiovascular, Neuroscience and Diabetes, but earnings beat signals remain mixed.

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.

Should You Hold Edwards Lifesciences Stock in Your Portfolio?

EW's TAVR and TMTT growth support its outlook, but currency pressure and intense competition remain key risks.

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 7.93% on an annualized basis producing an average annual return of 17.22%. Currently, Edwards Lifesciences has a market capitalizationread more...

Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?

Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.

$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 15.06%. Currently, Edwards Lifesciences has a market capitalizationread more...

Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation

Edwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.

Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?

Intuitive Surgical's da Vinci 5 is gaining rapid adoption, fueling hospital upgrades as software enhancements build a potential multi-year capital cycle.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Edwards Lifesciences Corp

Nvidia, Citi, AT&T, Lucid, Edwards Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.74	--	--	N/A
Q2 '26	$0.74	$0.78	4.97%	BEAT
Q1 '26	$0.73	$0.78	6.98%	BEAT
Q4 '25	$0.62	$0.58	-6.36%	MISSED
Q3 '25	$0.60	$0.67	12.39%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '26

Historical Earnings